The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Aratana Therapeutics Inc. Common 03874P101 6,171 1,117,875 SH   SOLE   1,117,875 0 0
Cerecor, Inc. Common 15671L109 2,221 595,436 SH   SOLE   595,436 0 0
Chiasma, Inc. Common 16706W102 52,043 5,681,544 SH   SOLE   5,681,544 0 0
CoLucid Pharmaceuticals, Inc. Common 19716T101 135 21,806 SH   SOLE   21,806 0 0
Conatus Pharmaceuticals, Inc. Common 20600T108 2,551 1,192,080 SH   SOLE   1,192,080 0 0
Endologix, Inc. Common 29266S106 9,375 1,121,447 SH   SOLE   1,121,447 0 0
EnteroMedics, Inc. Common 29365M307 72 74,206 SH   SOLE   74,206 0 0
EpiZyme, Inc. Common 29428V104 20,964 1,729,674 SH   SOLE   1,729,674 0 0
MacroGenics, Inc. Common 556099109 59 3,168 SH   SOLE   3,168 0 0
Mast Therapeutics, Inc. Common 576314108 689 2,551,851 SH   SOLE   2,551,851 0 0
Nevro Corporation Common 64157F103 8,439 150,000 SH   SOLE   150,000 0 0
Proteon Therapeutics, Inc. Common 74371L109 7,611 983,381 SH   SOLE   983,381 0 0
Radius Health, Inc. Common 750469207 183,335 5,831,253 SH   SOLE   5,831,253 0 0
Sangamo Biosciences, Inc. Common 800677106 136 22,487 SH   SOLE   22,487 0 0
Syndax Pharmaceuticals, Inc. Common 87164F105 28,887 2,168,691 SH   SOLE   2,168,691 0 0